Wei Zhang

Wei Zhang


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2020 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Open access
PDF file
YDYan Deng
Yan Deng
LLLei Lei
Lei Lei
YCYue Chen
Yue Chen
WZWei Zhang
Wei Zhang

3 May 2024 in IEEE Transactions on Very Large Scale Integration (VLSI) Systems
Verified
Journal Article
Closed access
ZLZhifei Lu
Zhifei Lu
BZBowen Zhang
Bowen Zhang
XPXizhu Peng
Xizhu Peng
HLHang Liu
Hang Liu
XYXiaoLei Ye
XiaoLei Ye
HTHe Tang
He Tang
This article presents a new artificial neural network (ANN)-based calibration mechanism for analog-to-digital converters (ADCs). The proposed mechanism applies ANN to realize the bijective vector recovery mapping (VRM) for nonlinearity calibration and thus effectively suppresses both harmonic distortions and spurs. A new ANN-based calibrator is designed to calibrate both single-channel nonlinearity and interchannel mismatches and significantly improve the performance of ADCs. Through signal-fitting-based training process and noise adding, the proposed mechanism and calibrator can calibrate the general nonlinearity and mismatches of ADCs, including but not limited to the typical nonideality that conventional calibration techniques commonly concern (such as interstage gain error, digital-to-analog converter (DAC) error, and timing mismatch). For verification, an on-chip ANN-based calibrator is implemented in a 12-bit 600-MS/s four-channel time-interleaved (TI) ADC prototype. The measurement results show that signal-to-noise-and-distortion ratio (SNDR) and spurious-free dynamic range (SFDR) are improved from 32.79 and 35.30 to 62.45 and 74.21 dB, respectively. Another off-chip ANN-based calibrator is applied to a commercial 12-bit 5.4-GS/s four-channel ADC, and the results show that the SNDR and SFDR are improved from 42.38 and 43.17 to 53.98 and 78.25 dB, respectively.

28 May 2022 in Materials Today Bio
Verified
Journal Article
Open access
LJLitao Jia
Litao Jia
PZPeiling Zhang
Peiling Zhang
ZCZheng Ci
Zheng Ci
XHXiaoyan Hao
Xiaoyan Hao
BBBaoshuai Bai
Baoshuai Bai
GZGuangdong Zhou
Guangdong Zhou
Functional repair of articular cartilage defects is always a great challenge in joint surgery clinically. Tissue engineering strategies that combine autologous cell implantation with three-dimensional scaffolds have proven effective for repairing articular cartilage tissue. However, it faces the problem of cell sources and scaffold materials. Autologous chondrocytes and bone marrow are difficult to popularize clinically due to limited donor sources and low mononuclear cell (MNC) concentrations, respectively. The density gradient centrifugation method can increase the concentration of MNCs in fresh bone marrow by nearly a hundredfold and achieve immediate enrichment. In addition, acellular cartilage matrix (ACM), with good biocompatibility and a cartilage-specific microenvironment, is considered to be an ideal candidate scaffold for cartilage regeneration. In this study, hybrid pigs were used to establish articular cartilage defect models of different sizes to determine the feasibility and maximum scope of application of ACM-based biomimetic scaffolds combined with MNCs for inducing articular cartilage regeneration. Importantly, ACM-based biomimetic scaffolds instantly enriched MNCs could improve the repair effect of articular cartilage defects in situ, which established a new model of articular cartilage regeneration that could be applied immediately and suited for large-scale clinical promotion. The current study significantly improves the repair effect of articular cartilage defects, which provides scientific evidence and detailed insights for future clinical applications of ACM-based biomimetic scaffolds combined with MNCs.

22 January 2024 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Closed access
PDF file
NLNan Liu
Nan Liu
QWQiang Wan
Qiang Wan
XWXiaoming Wu
Xiaoming Wu
TZTianzhi Zhao
Tianzhi Zhao
VJVivianne Jakobsson
Vivianne Jakobsson
WZWei Zhang
Wei Zhang

25 August 2022 in Diagnostic Pathology
Verified
Journal Article
Open access
PDF file
TYTong Yang
Tong Yang
EKEnhao Kang
Enhao Kang
LZLongxiao Zhang
Longxiao Zhang
JZJie Zhuang
Jie Zhuang
YLYujun Li
Yujun Li
WZWei Zhang
Wei Zhang
Aims: This study retrospectively investigated the morphological, immunohistochemical and molecular genetic features of papillary renal neoplasm with reverse polarity (PRNRP), a recently described renal tumor. Methods and results: Eleven cases of PRNRP were collected, and 16 cases of type I and 9 cases of type II papillary renal cell carcinoma were included as a control series. Pathological features were evaluated based on HE staining and immunohistochemistry. KRAS exon 2 and BRAF V600E mutations were detected by Real-time PCR and Sanger sequencing. Fluorescence in situ hybridization was conducted for identification of chromosomal abnormalities. Hemosiderin deposition was found in a small amount of tumor cells in 6 cases. Multifocal or patchy necrosis (5/11), small focal invasion of the pseudocapsules or renal parenchyma (6/11), and breakthrough of renal capsule with nerve invasion (1/11) were revealed, inconsistent with the previous view that the tumor lacks necrosis and intercellular hemosiderin. Immunohistochemical staining (diffusely positive for CK7 and GATA3, negative for CD117 and vimentin, and negative to weakly positive for P504S) and high frequency of KRAS mutations in exon 2 (9/10) supported the identification and inclusion of our cases. Chromosome 7 trisomy (1/7), chromosome 17 trisomy (0/7) and chromosome Y deletion (0/5 male patients) were seldom detected in this tumor. All patients were alive without metastasis or recurrence at the end of the follow-up. Conclusion: Our findings may highlight the possibility of a low malignant potential of this emerging entity. We suggest that the tumor be classified as a novel renal cell tumor subtype independent of papillary renal cell carcinoma.

3 November 2022 in Engineering with Computers
Verified
Journal Article
Closed access
PDF file
HXHuanwei Xu
Huanwei Xu
WZWei Zhang
Wei Zhang
NZNaixun Zhou
Naixun Zhou
LXLu Xiao
Lu Xiao
JZJingtian Zhang
Jingtian Zhang